Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study.
The Added Value of (Standard) Magnetic Resonance Imaging Compared to Transvaginal Ultrasound for the Preoperative Planning and Diagnosis of Deep Infiltrating Endometriosis: a Multicenter Retrospective Study.
1 other identifier
observational
200
1 country
1
Brief Summary
Several centers in Belgium use both transvaginal ultrasound (TVS) and magnetic resonance imaging (MRI) for the preoperative diagnosis of deep infiltrating endometriosis (DIE), while other centers rely almost exclusively on TVS. From the perspective of both the patient and the endometriosis care team, it is not primarily important that every individual lesion is mapped perfectly preoperatively, but rather that all lesions impacting clinical management and surgical planning are accurately detected. This is particularly crucial when a multidisciplinary approach is required, involving a urologist for bladder lesions and/or an abdominal surgeon for invasive rectosigmoid lesions. Moreover, providing the patient with thorough preoperative counseling is essential, and this is, of course, determined by the preoperative findings and the type of planned surgical procedure. In this study, we first assess the diagnostic performance of TVS in the preoperative diagnosis of DIE. As a secondary objective, we evaluate the added value of MRI compared to TVS for preoperative surgical planning in patients who also underwent an MRI examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2025
CompletedMay 29, 2025
May 1, 2025
2 months
May 20, 2025
May 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Accuracy of Transvaginal Sonography (TVS) for the preoperative planning of Deep Infiltrating Endometriosis (DIE)
The primary outcome of this study is to assess the diagnostic and preoperative planning performance of transvaginal sonography (TVS) in the preoperative detection of deep infiltrating endometriosis (DIE). TVS findings will be compared with intraoperative observations, classified according to the #ENZIAN system, to determine the sensitivity, specificity, and predictive values of TVS for various lesion locations.
From the diagnosis of deep infiltrating endometriosis (DIE) requiring surgical intervention to the surgical procedure itself.
Study Arms (2)
only transvaginal ultrasound
The TVE subgroup includes patients who underwent preoperative planning using transvaginal elastography (TVE) to assess tissue characteristics prior to Deep Infiltrating Endometriosis (DIE) surgery. This method was used to improve surgical planning by evaluating lesion stiffness and depth, aiding in the assessment of disease extent and potential surgical complexity.
transvaginal ultrasound and MRI
The TVE+MRI subgroup includes patients who underwent preoperative planning using both transvaginal elastography (TVE) and magnetic resonance imaging (MRI) prior to surgery for Deep Infiltrating Endometriosis (DIE). This combined approach aimed to enhance diagnostic accuracy and surgical planning by integrating tissue stiffness assessment from TVE with detailed anatomical visualization from MRI.
Eligibility Criteria
All patients who underwent preoperative imaging at AZ Sint-Jan AV and Ziekenhuis Oost-Limburg (ZOL) between October 2021 and December 2024, TVS with or without complementary MR followed by therapeutic surgery as part of DIE.
You may qualify if:
- All patients who underwent preoperative imaging at AZ Sint-Jan AV and Ziekenhuis Oost-Limburg (ZOL) between October 2021 and December 2024, TVS with or without complementary MR followed by therapeutic surgery as part of DIE.
You may not qualify if:
- Performing imaging, TVS with or without additional MR, by an operator without specific experience in the field.
- Lack of a TVS report diagnosing DIE.
- Preoperative diagnosis of only superficial endometriosis and/or endometriomas without DIE.
- Performance of surgery by a surgeon without specific experience in the field.
- Lack of a surgical report that correctly describes all DIE lesions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ziekenhuis Oost-Limburglead
- AZ Sint-Jan AVcollaborator
- Vrije Universiteit Brusselcollaborator
Study Sites (1)
Ziekenhuis Oost-Limburg
Genk, Limburg, 3600, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Van Holsbeke
Ziekenhuis Oost-Limburg
Central Study Contacts
Caroline Van Holsbeke
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 29, 2025
Study Start
June 1, 2025
Primary Completion
August 8, 2025
Study Completion
December 12, 2025
Last Updated
May 29, 2025
Record last verified: 2025-05